XWEL vs. TMDIF, AVGR, POAI, ATXI, VCNX, SILO, HOTH, PTIX, OGEN, and XCUR
Should you be buying XWELL stock or one of its competitors? The main competitors of XWELL include Titan Medical (TMDIF), Avinger (AVGR), Predictive Oncology (POAI), Avenue Therapeutics (ATXI), Vaccinex (VCNX), Silo Pharma (SILO), Hoth Therapeutics (HOTH), Protagenic Therapeutics (PTIX), Oragenics (OGEN), and Exicure (XCUR). These companies are all part of the "medical" sector.
Titan Medical (NASDAQ:TMDIF) and XWELL (NASDAQ:XWEL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings, dividends and community ranking.
XWELL has a consensus price target of $7.00, suggesting a potential upside of 288.89%. Given Titan Medical's higher probable upside, analysts clearly believe XWELL is more favorable than Titan Medical.
Titan Medical has a net margin of 0.00% compared to Titan Medical's net margin of -92.14%. XWELL's return on equity of 184.90% beat Titan Medical's return on equity.
In the previous week, XWELL had 3 more articles in the media than Titan Medical. MarketBeat recorded 3 mentions for XWELL and 0 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.48 beat XWELL's score of 0.00 indicating that XWELL is being referred to more favorably in the news media.
Titan Medical has higher earnings, but lower revenue than XWELL. XWELL is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
0.0% of Titan Medical shares are held by institutional investors. Comparatively, 8.7% of XWELL shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 4.9% of XWELL shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Titan Medical has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Comparatively, XWELL has a beta of 2.43, meaning that its stock price is 143% more volatile than the S&P 500.
XWELL received 3 more outperform votes than Titan Medical when rated by MarketBeat users.
Summary
XWELL beats Titan Medical on 9 of the 16 factors compared between the two stocks.
Get XWELL News Delivered to You Automatically
Sign up to receive the latest news and ratings for XWEL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding XWEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
